NASP is pleased to present the publication peer-reviewed abstracts that are part of the NASP 2023 Annual Meeting & Expo. NASP extends its heartfelt appreciation to the authors who are participating in the poster display of their work and are on hand to answer attendee questions to further expound on their research and results.
Publication
View all 2023 published abstracts in the Taylor & Francis MEDLINE-indexed journal Current Medical Research & Opinion (CMRO).
Categories of abstracts submissions included:
- Specialty Pharmacy Outcomes & Practice-Based Research
- Specialty Pharmacy Products, Services, or Programs
- Digital Engagement/Technology in Specialty Pharmacy Services
Abstracts accepted for presentation at the NASP Annual Meeting & Expo must reflect completed research and are based on the following: novelty of the research, significance of the findings, relevance to specialty pharmacy, and clarity. Submission of previously presented research is permitted.
2023 Poster Winners
With NASP members serving as poster judges, award winners will be announced on Thursday, September 21 in the following categories:
- Specialty Pharmacy Outcomes & Practice-Based Research: “Maximizing Cost Savings: The Impact of Specialty Pharmacist Interventions at a Community Oncology Center.” Presenting author: Casey Fitzpatrick, PharmD, BCPS, CPS Solutions.
- Specialty Pharmacy Products, Services, or Programs: “Impact of Integrating a Pharmacy Liaison Managed Care Model within a Diabetes Population.” Presenting author: Lillian Piz, M.S., Shields Health Solutions – Berkshire Health Systems.
- Digital Engagement/Technology in Specialty Pharmacy Services: “Oral Oncology Adverse Event Reporting via Text Messaging Integrative Collaboration Between Specialty Pharmacy and Oncology Provider Clinic.” Presenting author: Kelly Mathews, PharmD, CSP, Optum Specialty Pharmacy.
- Attendee Choice: “Impact of Pharmacist Intervention on the Collection of Sustained Virologic Response Tests in Patients Treated for Hepatitis C at a Health-System Specialty Pharmacy.” Presenting author: Samantha Manson, PharmD, MBA, WVU Medicine – Allied Health Solutions Specialty Pharmacy.
To view abstract posters, please click on the abstract titles below.
CE home study credit is available for pharmacists attending the 2023 Annual Meeting & Expo. Please click here for instructions on how to claim CE.
1: Health system owned specialty pharmacy provided laboratory monitoring for patients with multiple sclerosis receiving sphingosine 1-phosphate receptor modulators
Authors: Victoria McCarthy, PharmD, Jenna Stratman, PharmD, Carolyn Faylor, PharmD, Marco Pinto, BS, Anthony Donovan, PharmD
2: Impact of a Health System Specialty Pharmacy on Patient Engagement and Clinical Outcomes Post-Transition of Management
Authors: Casey Fitzpatrick, PharmD, BCPS; William G Waldron, RPh, MHA; Leigh Briscoe-Dwyer, PharmD, BCPS, FASH; Binoy Shah, PharmD, MBA; Fredrick Campogni, PharmD, BCMAS, 340B ACE, AAHIVP, CSP, DPLA; JessicaMourani, PharmD
3: A comprehensive approach to alleviate the pharmacy technician shortage and the implementation of a structured specialty pharmacy training program in a classroom setting
Authors: Bisni Narayanan, PharmD, MS; Brittany Dasher, BS, CPhT; Eric V. Buchsbaum, CPhT; Terri Sue Rubino, PharmD, CSP; Vinay Sawant, RPh, MPH, MBA
4: Biosimilar Perceptions Among Autoimmune Prescribers and Pharmacists in Health System Specialty Pharmacy
Authors: Jessica Mourani, PharmD; Carly Giavatto, PharmD; Casey Fitzpatrick, PharmD, BCPS; Adam Setter, PharmD; Larry Kobiska, PharmD,BS; Brandon Hardin, PharmD, MBA, CSP; Amber Skrtic, PharmD, CSP, AAHIVP; Amy Evans, PharmD, CSP; Eric Sredzinski, PharmD; SusanTrieu, PharmD; Ana I Lopez-Medina, PharmD
5: Education and evaluation strategies to implement a new care management documentation system in a health system specialty pharmacy
Authors: Sarah E. Wright, PharmD, BCACP; Kimhouy Tong, PharmD, BCPS; Robin D. Cullen, PharmD, MHA; Bisni Narayanan, PharmD, MS; Andrew Cadorette, PharmD; Eric V. Buchsbaum, CPhT; Esther Nowak, CPhT; Terri Sue Rubino, PharmD, CSP; Vinay Sawant, RPh, MPH, MBA
6: Opportunities Provided to Students through a Specialty Pharmacy Externship Program
Authors: Lauren Moy, BS, PharmD Candidate; Nehrin Khamo, PharmD, CSP; Michael Eagon, PharmD; Karen Thomas, PharmD, PhD, MBA
7: Optimizing initiation for self-injectable medications with remote demonstration kits delivered via specialty pharmacy
Authors: Sean Glynn, Todd Greenwood, Yash Prajapati, Xinyu Xu, Tim McLeroy, Joe Reynolds
8. Smart Strategies for Control Room Temperature Shipping of Mail Order Specialty Pharmaceuticals
Authors: Anthony Alleva, BA; Chantal Walker, MESc, CTP Level II; Ryan Sanders; Kevin Kohleriter, MBA; Jordan Bonomo, BS, BA
9: Abemaciclib Linkage to Care: A Health System Specialty Pharmacy Initiative
Authors: Chasity Mosby, PharmD Candidate; Ana Lopez Medina, PharmD; Casey Fitzpatrick, PharmD, BCPS; Jessica Mourani, PharmD; Steven Fosnight, PharmD; Megan Rees, PharmD, BCACP, CSP; Amber Skrtic, PharmD, CSP, AAHIVP; Katie Jo Cash, PharmD, CSP; Carly Giavatto, PharmD
10: Achieving Accreditation of Health System Specialty Pharmacies Through a Standardized Method
Authors: Patrick Ryan, PharmD, BCCCP, Lauren Mills; Danielle Rand, PharmD; Kate Campagnola, PharmD
11: Alternate Work Arrangement within Specialty Pharmacy
Authors: Alijah Kosarko, BA, CPhT; Bisni Narayanan, Pharm D, MS; Mitchell DelVecchio, Pharm D, CSP; Heather McKeon, BSHCA; Terri Sue Rubino, Pharm D, CSP; Vinay Sawant, RPh, MPH, MBA
12: Clinical Continuity Intervention for Newborns Exposed to Maternal HIV Infection
Authors: Aislinn Devoe, RN, MSN, CMSRN, CV-BC; Mark D’Ambrosi, RPh, CSP; Natalie Amendola BS, CPhT; Michele Riccardi, PharmD, BCPS; Nadia Yohannes, RPh; Tina Do, PharmD, MS, BCPS; Terri Sue Rubino, PharmD, CSP; Vinay Sawant, RPh, MPH, MBA
13: Expanding Patient Care Services to Solid Organ Transplant Patients by Establishing an Accredited Health System Specialty Pharmacy
Authors: Sonali Niyogi, PharmD, Shamsul Arif, PharmD, Marilyn Pitts, PharmD, BCPS
14: Impact of Integrating a Pharmacy Liaison-Managed Care Model within a Diabetes Population
Authors: David MacHaffie, RPh; Lillian Piz, MS; Nicholas Bull, PharmD; Shreevidya Periyasamy, MSHIA, Martha Stutsky, PharmD
15: Implementation of ambulatory clinical pharmacist type 2 diabetes care services within an integrated health-system specialty pharmacy
Authors: Sharon Zhu, PharmD; Veronica Sozio, PharmD, BCPS; Rachel Quinn, PharmD, BCACP, AE-C; Kathleen Horan, PharmD, BCACP; Kate Smullen, PharmD, MSCS; Martha Stutsky, PharmD, BCPS; Ameet Wattamwar, PharmD; Kenny Yu, PharmD, MBA, ACE
16: Pharmacy Integration into the Fertility Service Line: University Hospitals Specialty Pharmacy
Authors: Catherine N Seeco, PharmD; Alayna Manalo, CPhT; Allene Naples, PharmD, MBA, CSP
17: Respiratory Syncytial Virus (RSV) Protection: A Pan-Pharmacy Approach
Authors: Carrie Gatzke, PharmD, CSP; Jenny Carr, APRN, NNP-BC; Jessy Thomas, PharmD, MBA; and Morgan Osborn, PharmD
18: Addressing Social Determinants of Health: A Health System Specialty Pharmacy Initiative
Authors: Carly Giavatto, PharmD; Jacob Deisenroth BS, CPhT; Casey Fitzpatrick, PharmD, BCPS; Jessica Mourani, PharmD; Ana Lopez Medina, PharmD
19: Business Development Team Enhances Clinical Continuity by Leveraging Health System Partners
Authors: Tina Do, PharmD, MS, BCPS; Aislinn Devoe, MSN, CMSRN; Mark D’Ambrosi, RPh, CSP; Natalie Amendola, CPhT; Victoria Lucero, PharmD; Kimhouy Tong, PharmD, BCPS; Vinay Sawant, RPh, MPH, MBA
20: Developing a disease state specific patient management program at an integrated health system specialty pharmacy
Authors: Michele Riccardi, PharmD, BCPS; Kimhouy Tong, PharmD, BCPS; Todd Cooperman, PharmD, MBA; Sarah Wright, PharmD, BCACP; Terri Sue Rubino, PharmD, CSP; Tina Do, PharmD, MS, BCPS; Vinay Sawant, RPh, MPH, MBA
21: Effectiveness of Patient Navigation in Resolving Health-System Related Barriers to Care for Patients with Bleeding Disorders
Authors: Justin Lindhorst, MBA; Shelby Smoak Ph.D; Bill Wilbert; Brenda King; Kimberly Epps PharmD, CSP
23: Treatment patterns of intravenous edaravone in patients with amyotrophic lateral sclerosis: A retrospective administrative claims analysis
Authors: Malgorzata Ciepielewska, MS; Emma Richard, MPH; Yaoxuan Xia, MS; Hiangkiat Tan, MS, BPharm
24: Impact of a Clinical Pharmacist-Led Care Program on Patients with Hemophilia A, UtilizingTherigySTM
Authors: Lily Duong, PharmD, RPh; Khang Tran, PharmD, RPh; Abbas Dewji, PharmD, RPh, CSP; Catlin Goodfriend, PharmD, RPh; Jessica Mourani, PharmD; Casey Fitzpatrick, PharmD, BCPS; Carly Giavatto, PharmD
25: Application of PROs and PROMS as Interventions
Authors: Penny Surratt, BSN, RN, MBA; Sarah Kester, PharmD, RPh; Sulisa Chow, PharmD, RPh, MBA
26: Adherence and Discontinuation of Prescription Cannabidiol for the Management of Seizure Disorders at an Integrated Care Center
Authors: Paige Barnes, PharmD Candidate; Holly Dial, PharmD; Josh DeClercq, MS; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Kayla Johnson, PharmD, BCPS, BCPP
27: Adherence patterns in rheumatoid arthritis patients receiving a Janus Kinase (JAK) inhibitor or a Tumor Necrosis Factor a inhibitor after the addition of a black box warning to JAK inhibitors
Authors: W. Cliff Rutter, PharmD, PhD; Kunal Patel, PharmD; Samantha Delgado, PharmD, MS; Guy Cozzi, PharmD, CSP; Elisea Avalos-Reyes, PhD; Will Cavers, MS; Chen Liu; Rashmi Grover, PharmD; Lucia Feczko, RPh; Kjel Johnson, PharmD
28: Influence of seasonal changes on adherence in Rheumatoid Arthritis patients
Authors: Cody Schmidt, PhD-C; Kunal Patel, PharmD; Samantha Delgado, PharmD, MS; Guy Cozzi, PharmD, CSP; Elisea Avalos-Reyes, PhD; W. Cliff Rutter, PharmD, PhD; Rashmi Grover, PharmD; Lucia Feczko, RPh; Will Cavers, MSc; Kjel Johnson, PharmD
29: Clinical Outcomes Associated With Prescription Cannabidiol Use At 12-Months Post-Initiation
Authors: Kayla Johnson, PharmD, BCPS, BCPP; Paige Barnes, PharmD Candidate; Holly Dial, PharmD Candidate; Wendi Owens, CPhT; Josh DeClercq, MS; Leena Choi, PhD; Nisha B. Shah, PharmD; Shilpa Reddy, MD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP
30: Clinical Outcomes in Rheumatoid Arthritis Patients Enrolled in an Integrated Specialty Pharmacy Care Model
Authors: Carolkim Huynh, PharmD; Shreevidya Periyasamy, MS HIA; Kate Smullen, PharmD; Martha Stutsky, PharmD
31: Evaluating Patient-Reported Adherence and Outcomes in Specialty Disease States: A Dual Site Initiative
Authors: Chelsea P. Renfro, E. Danielle Bryan, Rebekah H. Anguiano, Lisa Kumor, Lauren Moy, Josh DeClercq, Leena Choi, Autumn D. Zuckerman
32: Evaluation of Inflammatory Bowel Disease Treatment Discontinuation Rates in Patients within Health System Specialty Pharmacy
Authors: Janese Bibbs, PharmD Candidate 2024; Katie Jo Cash, PharmD, CSP; Amy Evans, PharmD, CSP; Toni Zahorian, PharmD, BCACP; Amber Skrtic, PharmD, CSP, AAHIVP; Casey Fitzpatrick, PharmD, BCPS; Ana Lopez Medina, PharmD; Jessica Mourani PharmD; Carly Giavatto, PharmD
33: Hidden in plain sight: A data-driven approach to identifying patients earlier in their Alpha-1 antitrypsin deficiency diagnostic odyssey
Authors: Adam Reyna, PharmD; Jay Bryant-Wimp, RPh; Miranda Morrison, MBA, MPP
34: Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network
Authors: Martha Stutsky, PharmD; Dale Fasching, PharmD, MBA; Diana Miller; Laura West’ Carolkim Huynh, PharmD; Christopher Barr; Jennifer L. Donovan, PharmD
35: Impact of an Integrated Health System Specialty Pharmacy on HIV Clinical Outcomes
Authors: Elizabeth Maloy, PharmD, BCACP, CSP; Angelo Jones, PharmD, BCPS; Shreevidya Periyasamy, MS, HIA; Y. Caleb Chun, MA; Christopher Barr, Amy Riggs, PharmD, MBA, CSP; Jeremy Spires, PharmD; Jim Schwamburger, BS Pharm, MBA; Martha Stutsky, PharmD, BCPS
36: Impact of Health System Specialty Pharmacy Management on Clinical Outcomes in Patients with Asthma
Authors: Casey Fitzpatrick, PharmD, BCPS; Nicholas D’Angelo, PharmD, CSP, MSCS; Anthony Zuppelli, PharmD, CSP;Ryan VanSice, PharmD, BCPS, CSP; Ashley Blaakman, PharmD, CSP; Lauren Bryant, PharmD, CDCES; Jessica Mourani, PharmD; Nicole Griffith, PharmD, BCPS, AAHIVP
37: Impact of social determinants of health on multiple sclerosis adherence and persistence for patients using a national mail-order specialty pharmacy
Authors: Mona Modi, PharmD; Lauren Lawler, PharmD, CSP; Clarisse Purvis, PhD; Marwa Noureldin, PharmD, PhD, MS, BCGP; Kelly Mathews, PharmD, CSP
38: Impact of Specialty Pharmacy Implementation on Disease Burden and Quality of Life in Pediatric and Young Adult Patients Living with HIV
Authors: Tiffany M. Nason, PharmD; Susan D. Carr, PharmD; Timothy J. Howze, PharmD; Steve M. Pate, DPh; Joseph N. Sciasci, PharmD; Adejumoke Shofoluwe PharmD; Jacob B. Goss, BS; Najwa I. Stewart, BS; Nehali Patel MD
39: Adherence Rates of Sphingosine-1-Phosphate Receptor Modulators in Patients with Multiple Sclerosis
Authors: Slava Kachar, PharmD; Cliff Rutter, PharmD, PhD; Elisea Avalos-Reyes, PhD; Kelly McAuliff, PharmD; Rashmi Grover, PharmD; Lucia Feczko, RPh; Chen Liu, PhD; Dorothea Verbrugge, MD; Kjel Johnson, PharmD
40: Concomitant Apalutamide and Relugolix in Patients With High-Risk Localized Prostate Cancer: Testosterone Suppression 1-Year Update
Authors: Gordon Brown; Laurence Belkoff; Jason Hafron; Pankaj Aggarwal; Rushikesh Potdar; Amitabha Bhaumik; Jennifer Phillips; Tracy McGowan; Neal Shore
41: Multiple Switching Between the Biosimilar Adalimumab PF-06410293 and High-Concentration Reference Adalimumab in Combination With Methotrexate in Patients With Moderately to Severely Active Rheumatoid Arthritis
Authors: Mark Latymer, Daniel F Alvarez, Donna S Cox, Karen Wang, Wuyan Zhang
42: Patient-Oriented Eczema Measure (POEM) Scores to MeasurePatient Improvement with Specialty Medication for Atopic Dermatitis
Authors: Dana Simonson, PharmD, BCPS; Ann McNamara, PharmD; Ann Harty, PharmD; Alicia Zagel PhD, MPH
43: Real-world use of immunomodulators in patients receiving pegloticase for chronic gout
Authors: Christine Miller, PharmD; Drew Doyle, RPh; Barbara Prosser, RPh
44: Safety of Deutetrabenazine Above Food and Drug Administration Maximum Recommended Dose in Huntington’s Disease Chorea
Authors: Kayla Dodson, PharmD Candidate; Sabrina Livezey, PharmD, CSP; Kayla Johnson, PharmD, BCPS, BCPP; Josh DeClercq, MS; Autumn Zuckerman, PharmD, BCPS, CSP
45: Analyzing Data for Specialty Conditions Such as Hepatitis-C
Authors: Richard A Brook, MS, MBA; Ian A Beren, BS; Nathan L Kleinman, PhD; Eric M. Rosenberg, MA
46: COST ANALYSIS OF ONCE DAILY EXTENDED-RELEASE TACROLIMUS (LCPT) AND TWICE DAILY IMMEDIATE-RELEASE TACROLIMUS (IR-TAC) FOR KIDNEY TRANSPLANT PATIENTS
Authors: Keren Rodriguez, PHARMD, CSP; Chris Hayes, PHARMD; Rachel Chelewski, PHARMD, CSP; Autumn Zuckerman, PHARMD, BCPS, AAHIVP, CSP; Bridget Lynch, PHARMD; Ryan P Moore, MS; Jake Bell, BS, CPHT; Katie Cruchelow, PHD
47: FINANCIAL IMPACT OF INTEGRATED SPECIALTY PHARMACY EFFORTS TO AVOID ORAL ONCOLYTIC WASTE
Authors: Brooke D. Looney, PharmD, CSP; Jared Crumb, PharmD; Gabrielle Jones, PharmD candidate; Ryan Moore, MS; Leena Choi, PhD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Kristen Whelchel, PharmD, CSP
48: Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies
Authors: Chelsey Lindner, PharmD, BCOP, CSP; Y. Caleb Chun, MA; Shreevidya Periyasamy, MS, HIA; Christopher Barr; Dale Fasching, PharmD, MBA; Martha Stutsky, PharmD, BCPS
49: Maximizing Cost Savings: The Impact of Specialty Pharmacist Interventions at a Community Oncology Center
Authors: Megan Rees, PharmD, BCACP, CSP; Carly Giavatto, PharmD; Ana Lopez Medina, PharmD; Jessica Mourani, PharmD; Casey Fitzpatrick, PharmD, BCPS
50: RETRAINING OF TRANSPLANT PHARMACY STAFF TO REDUCE MEDICARE PART B PRESCRIPTION BILLING ERRORS IN POST-TRANSPLANT RECIPIENTS
Authors: Carey Vallone, CPhT;Sarah Osman, CPhT-Adv; KirstenMitchell, CPhT-Adv; Michael Wilson, CPhT; Chelsea Ray,CPhT; Keren Rodriguez, PharmD, CSP; Chris Hayes, PharmD; Rachel Chelewski, PharmD, CSP; Genevieve Staff, PharmD; Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP; Brianna Hawkins, MBA, PharmD Candidate, 2023; Katie Cruchelow, PhD
51: Rheumatoid Arthritis (RA) and non-infused biologics: adherence, healthcare cost and utilization
Authors: Staskon, F., PhD; Witt, E.A., PhD; Baiano, R., PharmD, CSP
52: Positive Impact of a Specialty Pharmacy Health Coach Program
Authors: Dana Simonson, PharmD, BCPS; Ann McNamara, PharmD; Holly Wiest, MA; Ann Harty, PharmD; Alicia Zagel PhD, MPH
53: A Comparison of Face-to-Face vs. Virtual Educational Nursing Support on Patient Compliance with Oral and Inhaled PAH Therapies
Authors: Evangelia Sourounis, PharmD, W. Cliff Rutter, PharmD, PhD, Elisea Avalos-Reyes, PhD, Frank Billick, BSN, RN, CRNI; Rashmi Grover, PharmD, Lucia Feczko, RPh and Kjel Johnson, PharmD
54: A model for medication therapy management service implementation in a health system specialty pharmacy
Authors: Athena Peterson, PharmD; Lauren Schwartz, PharmD, MBA; Bisni Narayanan, PharmD, MS; Terri Sue Rubino, PharmD, CSP; Vinay Sawant, MPH, MBA
55: Development and Implementation of Collaborative Pharmacy Practice Agreements in an Integrated Health System Specialty Pharmacy: A Qualitative Analysis
Authors: Chelsea P. Renfro, PharmD, CHSE; Katie H. Cruchelow, PhD; Matt Phillips, PharmD, MBA; Amy Mitchell, PharmD, CSP; Autumn D. Zuckerman, PharmD, BCPS, CSP
56: Disease Therapy Management for Medication Adherence in Rheumatoid Arthritis
Authors: Kyle Osborne, PharmD, BCPS, CSP; Gregory B Russell, MS; Nicole Cowgill, PharmD, BCOP, CSP, DPLA; Henry Chow, MD, CCD
57: Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacy
Authors: Nhi Bui, PharmD; Michaela Wachal, PharmD, CSP; Thomas Huynh, PharmD, CSP; Martha Stutsky, PharmD, BCPS
59: Impact of Pharmacist Intervention on the Collection of Sustained Virologic Response (SVR) Tests in Patients Treated for Hepatitis C at a Health-System Specialty Pharmacy
Authors: Samantha Manson, PharmD, MBA; Evan Turco, PharmD, BCPS; Kelsi Conant, PharmD, CSP; Rachel Mitchell, PharmD, BCPS, CSP
60: A Health System Specialty Pharmacy-led check-in Protocol in Patients on Oral Oncolytics
Authors: Amanda K. Cooper, PharmD; Khang Tran, PharmD; Lily Duong, PharmD; Abbas Dewji, PharmD, CSP; Carly Giavatto, PharmD; Casey Fitzpatrick, PharmD, BCPS; Jessica Mourani, PharmD, CSP; Jennifer Craig, PharmD, CSP; Reem AlQazzaz, PharmD, CSP
61: Achieving Quality Pharmacy Care for HIV Post Exposure Prophylaxis (PEP) Therapy
Authors: J. Cerulli, A. Harris, D. Morse, S. Przybyla, J. Cullen, A. Roberts, S. Guisinger, C. Cerulli
62: Clinical and Quality Outcomes of a Hypertrophic Cardiomyopathy Management Program within an Integrated Health System Specialty Pharmacy Model
Authors: Veronica Sozio, PharmD, BCPS; Martha Stutsky, PharmD, BCPS; Kerry Mello-Parker, PharmD, MBA; Robin Anderton, RN, MSN; Kate Smullen, PharmD, MSCS, Tatyana Cohen, PharmD, AE-C, IgCP; Shreevidya Periyasamy, MS, HIA; Ameet Wattamwar, PharmD; Kenny Yu, PharmD, MBA, ACE
63: Impact of PROMIS-10 on health-related quality-of-life outcomes in specialty pharmacy settings
Authors: Khang Tran, PharmD;Lily Duong, PharmD; Abbas Dewji, PharmD, CSP; Carly Giavatto, PharmD; Casey Fitzpatrick, PharmD, BCPS; Jessica Mourani, PharmD
64: Measuring prescription turnaround times in an integrated health system specialty pharmacy setting
Authors: Geri Buderwitz MBA, PharmD, Leandra Battisti PharmD, Benjamin Mohr MHA
65: Utilization of standard half-life or extended half-life products in members with Hemophilia A prescribed Hemlibra
Authors: Natalie Watkins, PharmD; Cliff Rutter, PharmD, PhD; Elisea Avalos-Reyes, PhD; Kelly McAuliff, PharmD; Chen Liu, PhD; Rashmi Grover, PharmD; Lucia Feczko, RPh; Dorothea Verbrugge, MD; Kjel Johnson, PharmD
66: Adherence to biologic therapies in patients with Ulcerative Colitis and Crohn’s disease: Analysis of a national specialty pharmacy and the MarketScan commercial claims database
Authors: Junlan Zhoua, Edward A. Witta, Mallory Schmolla
67: Difference in persistence between tablets and capsules
Authors: Shehla Zaidi, PharmD; Cliff Rutter, PharmD, PhD; Elisea Avalos-Reyes, PhD; Dipti Shah, PharmD, CSP; Kelly McAuliff, PharmD, BCOP, CSP; Rashmi Grover, PharmD; Lucia Feczko, RPh; Chen Liu, PhD; Emily Kipping, MA, MBA; Kjel Johnson, PharmD
68: Evaluating prior authorization turnaround times for integrated health system specialty pharmacy patients
Authors: Benjamin Mohr MHA, Geri Buderwitz MBA PharmD, Leandra Battisti PharmD
69: Impact of clinical dashboards for data capture and reporting across health system specialty pharmacies
Authors: Carson Kantoris, PharmD Candidate; Ana Lopez Medina, PharmD; Carly Giavatto, PharmD; Jessica Mourani, PharmD; Amber Skrtic, PharmD, CSP, AAHIVP; Hector Mayol Torres, BSEE; Erica Rosa, MPH;Casey Fitzpatrick, PharmD, BCPS
70: Individualized Care Plans’ Effect on Therapy Adherence for Patients Prescribed Olaparib
Authors: Yoona Kim, PharmD, PhD; Denise Tran, PharmD; Jordon Rabey, MS; Elaine Murphy, BS; Benjamin Matherne, MBA; Daniel Weaver, BSN, RN
71: Technology-Driven Delivery Performance, using predictive insight to take action…before shipping is even initiated
Author: Sebastian Pistritto, MBA
72: Development of a Workflow to Manage Non-specialty Medications at a Specialty Pharmacy
Authors: Mitchell DelVecchio, PharmD, CSP, Francesca Amici, PharmD, John Fitzgerald, PharmD, Alexandra Gianazza, PharmD, BCGP, NataliaKrupski, PharmD, Terri Sue Rubino, PharmD, CPS
73: Identifying Medication Access Barriers for Rare and Complex Disease Patients within the Pharmacy Hub Space
Authors: Luke Gross, PharmD; Kathleen Dawson, PharmD, MBA; Rami Chammas, PharmD, MPBA; Douglas Gebhard, PharmD, MBA; Kyle Davis, BA, MCTSDM; Gordon Vanscoy, PharmD, MBA, CACP
74: A landscape assessment of digital engagement with healthcare decision-makers
Authors: Joanna Ng; Jasmine Knight; Tasmina Hydery; Laurie Fazio
75: Implementation of a new patient case management system at a large health system specialty pharmacy
Authors: Kimhouy Tong, PharmD, BCPS; Terri Sue Rubino, PharmD; Andrew Cadorette, PharmD; Michele Riccardi, PharmD, BCPS; Sarah E. Wright, PharmD; BCACP; Vincent Do, PharmD, BCPS, BCTXP; Vinay Sawant, RPh, MBA
76: Optimize Your Patient Services to Support the Patient Treatment Journey
Authors: James Battaglia, John Giannouris, Stuart Kamin, Devansh Sheth
77: Oral oncology adverse event reporting via text messaging integrative collaboration between specialty pharmacy and oncology provider clinic
Authors: Meagan Pawlak, PharmD; Jessica Vinckier, PharmD CSP; Lauren Lawler, PharmD, CSP; Helen Kim, PharmD, BCGP; Jessica Lynton, PharmD, BCPS; Marwa Noureldin, PharmD, PhD, MS, BCGP; Kelly Mathews, PharmD, CSP
78: IMPACT OF MULTI-STEP ORDER TRANSMITTAL IN AN INFLAMMATORY BOWEL DISEASE CLINIC
Authors: Caroline Hammond, PharmD; Alyssa Stewart, PharmD, BCACP, CSP, CPP; Kathy Bricker, PharmD, BCPS, DPLA; Jennifer Young, PharmD, BCPS, CSP; Kyle Hansen, PharmD, MS, BCPS, CSP
79: High Patient Engagement with a Pharmacy-Created Digital Refill Program
Authors: Katie Moore, PharmD, CSP; Clint Ivie, PharmD, MBA, CSP
80: Improving Medication Adherence Documentation for Specialty Pharmacy Patients
Authors: Hayley O’Rourke, PharmD, CSP, Kaitlin Ciaramitaro, PharmD, MHA, CSP, Ryan H. Lackey, PharmD
81: The Implementation of Agile Methodology and its Impact on the Healthcare and Pharmacy Technology Industry
Authors: Samuel Aronson, PharmD; Kathleen Dawson, PharmD, MBA; Rami Chammas, PharmD, MPBA; Douglas Gebhard, PharmD, MBA; Gordon Vanscoy, PharmD, MBA, CACP